Related Experiment Video
Updated: Jul 25, 2025

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
Published on: January 5, 2024
A Randomized Parallel-group Study of Digital Gut-directed Hypnotherapy vs Muscle Relaxation for Irritable Bowel
Sameer K Berry1, Rani Berry2, David Recker3
1New York Gastroenterology Associates, New York, New York.
Digital gut-directed hypnotherapy (GDH) improved abdominal pain and stool symptoms in adults with irritable bowel syndrome (IBS). This digital program offers a scalable solution for IBS management, enhancing accessibility to effective treatments.
Area of Science:
- Gastroenterology
- Psychosomatic Medicine
- Digital Health
Background:
- Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder.
- Gut-directed hypnotherapy (GDH) is an effective IBS treatment, but accessibility is limited.
- Digital delivery of GDH may improve access to care.
Purpose of the Study:
- To compare the safety and efficacy of a self-administered, digital GDH program versus digital muscle relaxation (MR) in adults with IBS.
- To evaluate the impact of digital GDH on abdominal pain, stool consistency, and stool frequency.
Main Methods:
- A randomized controlled trial involving 378 adults with IBS.
- Participants were randomized to 12 weeks of digital GDH (Regulora) or digital MR via a mobile app.
- Primary endpoint: abdominal pain response (≥30% reduction in pain intensity).
Main Results:
- 362 patients were included in the efficacy analysis.
- While the primary endpoint showed no significant difference, digital GDH significantly increased abdominal pain responders during late treatment (30.9% vs 21.5%) and overall (29.3% vs 18.8%).
- Improvements in pain, stool consistency, and frequency were observed across IBS subtypes with no serious adverse events.
Conclusions:
- Digital GDH programs can improve abdominal pain and stool symptoms in IBS patients.
- This intervention shows promise as part of integrated care for IBS.
- Digital GDH offers a scalable and accessible treatment option for IBS management.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Constipation-Predominant IBS

